Cell and Gene Therapy (CGT): Pre-launch checklist
By AmerisourceBergen
Ten questions to ask yourself and your commercialization partner
As they embark on the commercialization path, it is essential for cell and gene therapy (CGT) developers, who invest their time, expertise, and financial resources to create groundbreaking therapies that profoundly impact patients' lives, to position themselves for optimal market access by engaging with the right stakeholders. Discover how selecting the right integrated commercialization solutions partner can help position your product for success.
The right partner will help streamline the intricate pre-launch process, assist you in tackling challenging decisions related to market access, distribution strategies, patient services, and more―ensuring all bases are covered.
Enter your information below to download the checklist and discover the ten questions to ask yourself and your commercialization partner to chart a comprehensive strategy that aims to support the successful advancement of your therapy.
Topics:
Cell and gene therapy